Preimplantation Genetic Testing (PGT) Market expected to value at USD 221.1 million by 2024

 The global preimplantation genetic testing (PGD/PGT) market is expected to value at USD 221.1 million by 2024. The market is subject to witness a substantial growth due to the rising awareness in regards to genetic techniques and increasing adoption for detection of chromosomal abnormalities. Use of preimplantation genetic testing (PGD/PGS) for embryo screening to perform in vitro fertilization (IVF) is expected to boost market growth over the forecast period. Identification of genetic disorders and inherited conditions with the help of preimplantation genetic testing (PGT) and diagnosis is predicted to foster market growth over the upcoming years.


Globally, the preimplantation genetic testing industry is predicted to grow at higher CAGR in the forecast period, providing numerous opportunities for market players to invest for research and development in the preimplantation genetic testing market. Early diagnosis of the chromosomal disorders helps to reduce the number of people suffering from congenital diseases. These factors are anticipated to fuel demand for preimplantation genetic testing (PGT) solutions. Increasing number of incidences of various gene-related disorders is estimated to favor market growth over the next seven years.


Genetic testing identifies differences among genes that are related with disease or other behaviors. The genetic tests determine person susceptibility towards genetic disease. The testing also helps to understand the likelihood of a person to carry forward genetic mutation to their offspring. Preimplantation genetic testing is performed on various blood sample taken during different period in person’s life, for example, before the birth and until death of the individual. The fast paced technological advancement in genetic testing and sequencing methodologies, has led to the vast expansion of genetic testing in numerous health care sections to determine individual’s susceptibility towards complex disorders.


Download Free sample Report 

https://www.millioninsights.com/industry-reports/preimplantation-genetic-testing-market/request-sample


Pre-implantation genetic diagnosis (PGD or PIGD) is also referred as the genetic profiling of embryos prior to implantation. Pre-implantation genetic diagnosis (PGD or PIGD) is also used for profiling of oocytes prior to fertilization. Pre-implantation genetic diagnosis is carried out in similar way as that of prenatal diagnosis. Pre-implantation genetic diagnosis offer benefits such as selective pregnancy termination thus ensuring the baby will be free of the disease under consideration. Pre-implantation genetic diagnosis uses in vitro fertilization (IVF) to achieve oocytes or embryos for evaluation.


The preimplantation genetic testing (PGT) industry is broadly categorized into four major segments based on the application type such as embryo HLA typing for stem cell therapy, IVF prognosis, late-onset genetic disorders, and inherited genetic disease. The embryo HLA typing for stem cell therapy is considered as one of the fastest growing segment in the preimplantation genetic testing (PGT) market with substantial revenue generation in the last few years.


Growing popularity of preimplantation genetic testing in the embryo HLA typing for stem cell therapy segment is attributed to increasing implementation of the hematopoietic stem cell transplantations via matched donors and significant improvements in overall survival rate.


The preimplantation genetic testing industry is divided by region as North America, Europe, Asia-Pacific, Latin America and Africa. North America has shown major growth in recent years owing to the rise in the implementation of latest technologies in medicine & pharmaceutical sector, increase in the number of research & development activities in the region, and existence of well-established healthcare infrastructure.


Asia-Pacific region is predicted to hold major market share in the preimplantation genetic testing market with massive growth in forecast period. Countries such as Japan, China and South Korea are leading the Asia-Pacific market with rising healthcare expenditure, strong economic region, and significant investment by leading industry players considering potential growth opportunities in the region.


Browse Full Research Report with TOC:  https://www.millioninsights.com/industry-reports/preimplantation-genetic-testing-market


The key players in the preimplantation genetic testing industry are Quest Diagnostics, Inc., Reproductive Health Science Ltd., Natera, Inc., Cooper Surgical, Inc., Genea Ltd., Good Start Genetics, Inc., Lab Co., California Pacific Medical Center, Thermo Fisher Scientific, Inc., Bioarray S.L., Illumina, Inc., Igenomix Co., Reproductive Genetic Innovations LLC, F. Hoffmann-La Roche AG, and CombiMatrix Co.


Market Segment:


Type Outlook (Market Revenue in USD Million, 2013 - 2024)

    • Chromosomal Abnormalities

    • X-linked Diseases

    • Freeze Embryo Testing

    • Aneuploidy Screening

    • HLA Typing

    • Other PGT Types


Application Outlook (Revenue in USD Million, 2013 - 2024)

    • Embryo HLA Typing for Stem Cell Therapy

    • IVF Prognosis

    • Late-Onset Genetic Disorders

    • Inherited Genetic Disease

    • Others


Regional Outlook (Market Revenue in USD Million, 2013 - 2024)

    • North America

        • U.S.

        • Canada

    • Europe

        • Germany

        • UK

    • Asia Pacific

        • Japan

        • China


continue........


Get In Touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.


Contact Person: 

Ryan Manuel

Research Support Specialist, USA

Email: ryan@millioninsights.com


Global Headquarters

Million Insights

Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States

Phone: 1-408-610-2300

Email: sales@millioninsights.com


Asia Pacific

Million Insights

Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India

Phone: 91-20-65300184

 

 


Comments

Post a Comment

Popular posts from this blog

(Europe, Middle East and Africa) Herbal Medicine Market Size and Forecast up, 2017: Radiant Insights, Inc

In this report, the EMEA Herbal Medicine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Herbal Medicine for these regions, from 2012 to 2022 (forecast) Europe: Germany, France, UK, Russia, Italy and Benelux; Middle East: Saudi Arabia, Israel, UAE and Iran; Africa: South Africa, Nigeria, Egypt and Algeria. Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/emea-europe-middle-east-and-africa-herbal-medicine-industry-2017/request-sample EMEA Herbal Medicine market competition by top manufacturers/players, with Herbal Medicine sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including Tsumura Schwabe Madaus
Read more

Global Softgel Capsules Market Demand and Analysis of Key Players – Research Forecast to 2021

13-feb-2019  A Softgel capsule is an oral form of medicine that is usually consists of a gelatin-based shell that has a liquid fill in it. It is basically a mixture of opacifier, gelatin, water, and a plasticizer. The market is currently undergoing a major trend of burgeoning consumer supplements consumption, and growth in the market opportunities.  A wide range of applications are attached with the use of the capsule ranging from formation of anti-inflammatory drugs, antibiotic and antibacterial drugs, cardiovascular therapy drugs, cough and cold preparations, health supplements, and other vitamins and dietary supplements. They are also said to be useful for the preparation of antacid, antiflatulent and antianemic. The product is gaining huge recognition across the globe due to its rising applications and prerequisites. The key factors that are playing a key role in raising the share of the market may include rise in the research and development, rising applications, increasing d
Read more

Psychiatrists Global Market Opportunities, Drivers, Growth Potential, Industry Challenges and Risks to 2023

Psychiatrists Global Market Opportunities And Strategies To 2023 from Radiant Insights,Inc provides the strategists, marketers and senior management with the critical information they need to assess the global Psychiatrists market. Description: Where is the largest and fastest growing market for the Psychiatrists market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global Psychiatrists market opportunities and strategies to 2023 report from the Business Research Company answers all these questions and many more. The report covers the following chapters • Executive Summary - The executive summary section of the report gives a brief overview and summary of the report • Report Structure - This section gives the structure of the report and the information covered in the various sections. • Introduction - This section gives the segmentation of the psychiatrists market by geography, by
Read more